Peg Horn

Peg Horn

Directeur des opérations chez REVOLUTION MEDICINES, INC.

Fortune : 24 M $ au 31/05/2026

63 ans
Health Technology
Consumer Services
Commercial Services

Profil

Margaret A. Horn is currently an Independent Director at Sangamo Therapeutics, Inc. since 2022.
She serves as Secretary & General Counsel at Genencor International, Inc. since 1991.
She is a Member of The State Bar of California and the Pennsylvania State Bar Association.
She is Chief Operating Officer at Revolution Medicines, Inc. since 2018.
Formerly, Ms. Horn was General Counsel & Secretary at Kosan Biosciences, Inc. from 2005 to 2007.
She was SVP-Corporate Development & General Counsel at Cogentus Pharmaceuticals, Inc. in 2009.
She worked as Principal at E.I.
du Pont de Nemours & Co. She was Chief Operating Officer at Prolynx LLC from 2010 to 2014.
Education includes undergraduate studies at the University of the Sciences in Philadelphia, graduate studies at Charles Widger School of Law, and an MBA from The Pennsylvania State University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
17/06/2026 154 647 ( 0,07 % ) 24 M $ 31/05/2026
12/06/2025 82 650 ( 0,02 % ) 18 018 $ 31/05/2026

Postes actifs de Peg Horn

SociétésPosteDébut
REVOLUTION MEDICINES, INC. Directeur des opérations 01/10/2018
SANGAMO THERAPEUTICS, INC. Directeur/Membre du Conseil 15/12/2022
Conseiller Juridique Général 01/01/1991
Corporate Officer/Principal -
Corporate Officer/Principal -

Anciens postes connus de Peg Horn

SociétésPosteFin
Directeur des opérations 01/12/2014
Conseiller Juridique Général 18/12/2009
Corporate Officer/Principal -
Conseiller Juridique Général 24/08/2007
Voir l'expérience en détail de Peg Horn

Formation de Peg Horn

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

81

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Health Technology

Health Technology

Health Technology

Process Industries

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Commercial Services

Consumer Services

-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇